In this review, we will discuss the possibility of considering the Helios transcription factor (encoded by the IKZF2 gene) as a potential biomarker and therapeutic target in systemic lupus erythematosus (SLE), a relatively common autoimmune disease. The gene discussed is IKZF2; the disease is autoimmune disease.